1st Quarter - Report · 2026

Filing UUID: 07e97337-57a3-418b-b1a5-237289ded861
Type: Q1 — 1st Quarter - Report
Period: first_quarter
Year: 2026
Posted: 2026-04-16 19:53:54
Income (reported): $60,000
Expenses (reported): —
Filing document: Open on lda.senate.gov

Registrant (lobbying firm)

CAPITOL COUNSEL LLC

Government affairs.

Contact: TRACEY A. GRAY
Phone: +1 202-861-3200
Address: zip:20005, city:Washington, state:DC, street:700 13th Street NW, 2nd Floor

Client

ALNYLAM PHARMACEUTICALS, INC.

Pharmaceutical manufacturer.

State: MA
Country: US
Effective date: 2025-02-01

Issues lobbied + lobbyists

`MED` — Medical/Disease Research/Clinical Labs

Issues regarding FDA guidance on Platform Technology Platform Technology Designation Program for Drug Development.

Lobbyists: JOHN MARTIN; JEFFREY CARROLL

Government entities lobbied: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.